新闻
SONN
--
0.00%
--
21 只股票在周一的盘前交易时段变动
Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.
Benzinga · 1天前
Sonnet BioTherapeutics 表示收到了纳斯达克股票市场上市资格人员的来信
-8K Filing
8K Filing · 10/07 20:56
18 只股票在周一的盘前交易时段变动
Gainers CohBar, Inc. (NASDAQ: CWBR) rose 22.8% to $1.13 in pre-market trading after dropping over 4% on Friday.
Benzinga · 10/04 11:00
38 只股票在周三的午盘交易中移动
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.
Benzinga · 09/15 16:01
BTIG 以买入评级启动对 Sonnet BioTherapeutics 的覆盖,宣布目标价为 5 美元
BTIG initiates coverage on Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy rating and announces Price Target of $5.
Benzinga · 09/15 11:28
--BTIG 以 5 美元的目标价买入 Sonnet BioTherapeutics Holdings
MT Newswires · 09/15 09:34
2021年9月1日公司新闻
Zacks.com · 09/01 13:41
午后市场更新:Spok Holdings 因收购要约而飙升;连续品牌份额下滑
Toward the end of trading Tuesday, the Dow traded down 0.09% to 35,366.93 while the NASDAQ fell 0.02% to 15,263.43. The S&P also fell, dropping 0.11% to 4,523.94.
Benzinga · 08/31 18:26
午间市场更新:第二季度业绩公布后 Zoom 股价下跌; AC Immune 股价飙升
Midway through trading Tuesday, the Dow traded down 0.01% to 35,396.15 while the NASDAQ fell 0.25% to 15,227.25. The S&P also fell, dropping 0.09% to 4,524.67.
Benzinga · 08/31 16:13
33 只股票在周二的中盘交易
Gainers
Benzinga · 08/31 16:05
为什么 Sonnet BioTherapeutics 股票今天交易更高
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) is trading significantly higher Tuesday after the company announced the successful completion of the discovery phase for its next preclinical pipeline candidate, SON-1410.
Benzinga · 08/31 13:57
Brief-Sonet Biotherapeutics 启动 SON-1410 的制造过程
reuters.com · 08/31 13:36
12 只医疗保健股在周一的盘后交易时段内移动
Gainers
Benzinga · 08/31 13:32
The Daily Biotech Pulse:VectivBio 在并购组合中,Sonnet Biotherapeutics 将候选人推向诊所,加拉帕戈斯群岛的首席执行官转型,Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)
Benzinga · 08/31 12:05
18 只股票在周二的盘前交易时段内波动
Gainers Regional Health Properties Inc (NYSE: RHE) rose 50.3% to $12.49 in pre-market trading after jumping over 15% on Monday. The company, earlier during the month, reported Q2 results.
Benzinga · 08/31 11:33
Sonnet 称小鼠的复合缩小肿瘤;股价飞跃
MT Newswires · 08/31 10:48
看看为什么 Sonnet BioTherapeutics 股票周二在上市前飙升
Benzinga · 08/31 09:43
Sonnet BioTherapeutic(SONN.US)盘前暴涨55%
Sonnet BioTherapeutic(SONN.US)盘前暴涨55%
格隆汇 · 08/31 08:53
Sonnet 宣布完成其下一个临床前候选管线 (SON-1410) 的发现阶段
Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it has selected a novel development candidate after completing
Benzinga · 08/30 20:02
Sonnet 宣布其下一个临床前候选药物 (SON-1410) 的发现阶段已成功完成
/ Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it has selected a novel development candidate after completing comparative studies in a mouse melanoma mo...
ACCESSWIRE · 08/30 20:01
微牛提供丰富的实时SONN股票新闻,让你可以通过多个平台了解SONN股票行情最新动态,这些免费的Sonnet BioTherapeutics Inc新闻可以帮助你做出明智投资。
SONN 简况
Sonnet Biotherapeutics Holdings Inc(原名:Chanticleer Holdings, Inc.)为肿瘤专家生物技术公司。该公司正在开发具有增强的单特异性或双特异性机制的靶向生物药物。